Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 17, 2024

SELL
$0.42 - $0.72 $164,607 - $282,184
-391,923 Reduced 1.19%
32,550,683 $20.5 Million
Q3 2023

Oct 18, 2023

BUY
$0.6 - $1.53 $407,803 - $1.04 Million
679,672 Added 2.11%
32,942,606 $19.8 Million
Q2 2023

Jul 10, 2023

BUY
$1.05 - $1.63 $978,172 - $1.52 Million
931,593 Added 2.97%
32,262,934 $36.5 Million
Q1 2023

Apr 17, 2023

BUY
$1.2 - $2.73 $5.11 Million - $11.6 Million
4,258,497 Added 15.73%
31,331,341 $42.3 Million
Q4 2022

Jan 24, 2023

SELL
$1.71 - $3.61 $5.81 Million - $12.3 Million
-3,395,537 Reduced 11.14%
27,072,844 $0
Q3 2022

Oct 17, 2022

BUY
$1.9 - $8.63 $3.42 Million - $15.5 Million
1,799,431 Added 6.28%
30,468,381 $75 Million
Q2 2022

Jul 11, 2022

BUY
$2.13 - $9.01 $2.1 Million - $8.89 Million
986,724 Added 3.56%
28,668,950 $105 Million
Q1 2022

Apr 19, 2022

BUY
$6.28 - $15.59 $6.16 Million - $15.3 Million
981,413 Added 3.68%
27,682,226 $221 Million
Q4 2021

Jan 28, 2022

BUY
$14.7 - $28.67 $11.5 Million - $22.4 Million
782,927 Added 3.02%
26,700,813 $408 Million
Q3 2021

Nov 12, 2021

BUY
$24.31 - $33.6 $110 Million - $152 Million
4,517,656 Added 21.11%
25,917,886 $737 Million
Q2 2021

Aug 05, 2021

SELL
$26.09 - $40.4 $67.2 Million - $104 Million
-2,577,578 Reduced 10.75%
21,400,230 $722 Million
Q1 2021

May 13, 2021

SELL
$33.06 - $56.93 $100 Million - $172 Million
-3,023,330 Reduced 11.2%
23,977,808 $916 Million
Q4 2020

Feb 12, 2021

SELL
$39.09 - $57.4 $29.5 Million - $43.3 Million
-753,601 Reduced 2.72%
27,001,138 $1.13 Billion
Q3 2020

Oct 30, 2020

BUY
$28.43 - $44.67 $112 Million - $176 Million
3,934,027 Added 16.52%
27,754,739 $1.2 Billion
Q2 2020

Aug 11, 2020

BUY
$11.71 - $30.29 $90.5 Million - $234 Million
7,725,962 Added 48.0%
23,820,712 $722 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $42.7 Million - $154 Million
5,585,618 Added 53.15%
16,094,750 $220 Million
Q4 2019

Jan 31, 2020

BUY
$15.02 - $20.57 $40.1 Million - $54.9 Million
2,667,936 Added 34.02%
10,509,132 $170 Million
Q3 2019

Nov 12, 2019

SELL
$18.85 - $27.5 $29.8 Million - $43.5 Million
-1,581,961 Reduced 16.79%
7,841,196 $151 Million
Q2 2019

Jul 30, 2019

BUY
$17.37 - $26.27 $12 Million - $18.2 Million
693,634 Added 7.95%
9,423,157 $221 Million
Q1 2019

May 13, 2019

SELL
$10.65 - $25.75 $431,857 - $1.04 Million
-40,550 Reduced 0.46%
8,729,523 $204 Million
Q4 2018

Feb 01, 2019

SELL
$9.26 - $16.38 $3.7 Million - $6.55 Million
-400,083 Reduced 4.36%
8,770,073 $97 Million
Q3 2018

Nov 07, 2018

BUY
$7.54 - $18.31 $2.68 Million - $6.52 Million
355,929 Added 4.04%
9,170,156 $153 Million
Q2 2018

Aug 07, 2018

BUY
$4.87 - $8.42 $9.19 Million - $15.9 Million
1,886,952 Added 27.24%
8,814,227 $64.8 Million
Q1 2018

May 14, 2018

BUY
$4.69 - $10.05 $22.6 Million - $48.5 Million
4,822,477 Added 229.12%
6,927,275 $32.5 Million
Q4 2017

Feb 12, 2018

BUY
$7.86 - $9.99 $5.06 Million - $6.43 Million
643,860 Added 44.07%
2,104,798 $19.1 Million
Q3 2017

Nov 09, 2017

BUY
$8.89 - $10.4 $4.26 Million - $4.98 Million
478,768 Added 48.75%
1,460,938 $13.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
229,189 Added 30.44%
982,170 $9.39 Million
Q1 2017

May 15, 2017

BUY
N/A
86,411 Added 12.96%
752,981 $8.33 Million
Q4 2016

Feb 13, 2017

BUY
N/A
666,570
666,570 $5.29 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.